Connection

RICHARD ERIC DAVIS to Gene Expression Profiling

This is a "connection" page, showing publications RICHARD ERIC DAVIS has written about Gene Expression Profiling.
Connection Strength

0.624
  1. Effect of long-term storage in TRIzol on microarray-based gene expression profiling. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2445-52.
    View in: PubMed
    Score: 0.160
  2. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet. 2005 Aug 05; 137B(1):5-16.
    View in: PubMed
    Score: 0.113
  3. Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr Opin Hematol. 2002 Jul; 9(4):333-8.
    View in: PubMed
    Score: 0.091
  4. XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cells. Leuk Res. 2013 Aug; 37(8):974-9.
    View in: PubMed
    Score: 0.048
  5. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev. 2006 Apr; 210:67-85.
    View in: PubMed
    Score: 0.029
  6. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis. 2004 Jan; 10(1):1-14.
    View in: PubMed
    Score: 0.025
  7. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003 Jun 15; 101(12):4944-51.
    View in: PubMed
    Score: 0.024
  8. Biomarkers of human skin cells identified using DermArray DNA arrays and new bioinformatics methods. Biochem Biophys Res Commun. 2002 Mar 08; 291(4):1052-64.
    View in: PubMed
    Score: 0.022
  9. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2001 Dec 17; 194(12):1861-74.
    View in: PubMed
    Score: 0.022
  10. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000 Feb 03; 403(6769):503-11.
    View in: PubMed
    Score: 0.019
  11. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol. 1999; 64:71-8.
    View in: PubMed
    Score: 0.018
  12. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-?B mediates chemoresistance. Blood. 2014 Apr 24; 123(17):2691-702.
    View in: PubMed
    Score: 0.013
  13. Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma. Blood. 2012 Oct 18; 120(16):3260-70.
    View in: PubMed
    Score: 0.011
  14. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A. 2008 Sep 09; 105(36):13520-5.
    View in: PubMed
    Score: 0.009
  15. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007 Aug; 12(2):115-30.
    View in: PubMed
    Score: 0.008
  16. A method to improve selection of molecular targets by circumventing the ADME pharmacokinetic system utilizing PharmArray DNA microarrays. Biochem Biophys Res Commun. 2003 Apr 11; 303(3):828-41.
    View in: PubMed
    Score: 0.006
  17. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol. 2001; 2(10):RESEARCH0041.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.